Innate Pharma
IPHA
#8794
Rank
$0.15 B
Marketcap
$1.70
Share price
0.59%
Change (1 day)
-27.35%
Change (1 year)

Half-year Reports

Thumbnail Innate Pharma
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2024-h1

Half-year Report 2024-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: French

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2020-h1

Half-year Report 2020-h1

Language: French

View Half-year Report